Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 30, 2013BrainOpen Access

Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer’s disease

View Full Paper
Ask AI
Bookmark
Share

Authors

YLYen Ying LimMonash UniversityPMPaul MaruffEdith Cowan UniversityRPRobert H. PietrzakUniversity of North Carolina at Chapel Hill

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lim et al. (2013) studied this question.

synapsesocial.com/papers/6a2daa435da9e99106d13098https://doi.org/10.1093/brain/awt286
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Decline in Cognitive Function over 18 Months in Healthy Older Adults with High Amyloid-β2013 · 47 citations
  2. 2Statistical Power Analysis for the Behavioral Sciences1989 · 16,521 citations
  3. 3Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline2012 · 231 citations
  4. 4Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease2011 · 7,310 citations
  5. 5Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease2011 · 840 citations